Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "David Cordani"


3 mentions found


Read previewHealth insurance giant Cigna is exiting the lucrative senior business that's been a boon to insurers' bottom lines for years. It's a sign that the glory days of Medicare Advantage might be coming to an end. Cigna's senior business isn't the biggest, but it's also nothing to sneeze at. In January, Humana, the second-largest Medicare Advantage insurer with 6 million members, slashed its profit projections because of these costs. AdvertisementIn late 2023, rumors swirled that Cigna was looking to sell its Medicare Advantage plans so it could pull off a merger with Humana—the second-largest Medicare Advantage insurer.
Persons: , that's, Cigna, it's, It's, David Cordani, Cordani, Gary Taylor, Cowen, Taylor, Dean Ungar, Humana, Ungar Organizations: Service, Health Care Service Corp, Medicare, Business, Kaiser Family Foundation, Competition, Humana, Moody's Investors Service Locations: Illinois
Demand for expensive weight-loss drugs such as Ozempic and Wegovy is soaring. Companies that foot the bill for their workers' health coverage are mulling whether to pay for them. Across the US, companies are facing a critical decision: whether to foot the bill for the expensive weight-loss drugs that have exploded in popularity in recent months. Andrews estimated that more than half the companies in the alliance covered weight-loss drugs. Andrews' comments offer a window into how big US companies are grappling with the rising demand for and high costs of weight-loss treatment.
Cigna CEO David Cordani talks quarterly results with Jim CramerCigna CEO David Cordani joins 'Mad Money' host Jim Cramer to talk Cigna's quarterly earnings results and political preassure on the healthcare sector.
Total: 3